Introduction

Several ion channels implicated in central and peripheral nervous system disorders, including ischemic stroke, Alzheimer’s disease, and multiple sclerosis. These channels represent critical therapeutic targets for neuroprotection, reducing neuronal damage, and managing neurodegenerative symptoms.

Neurodegeneration/stroke ion channel Portfolio

Our neurodegeneration/stroke ion channel portfolio is a curated collection of ion channels that have been implicated in the treatment and etiology of neurodegenerative diseases and stroke. This panel is designed to assess a compound's target specificity and potential off-target effects, which is crucial for the discovery of drugs that can effectively manage neurodegenerative conditions and stroke-related complications.

The Neurodegeneration/Stroke Ion Channel Portfolio is a powerful tool in the early stages of drug discovery, offering a focused approach to identifying and profiling ion channels that are critical in neurodegenerative and stroke-related conditions. By targeting these channels, we can accelerate the development of novel therapeutics with improved selectivity and efficacy.